Point72 Middle East Fze Becton Dickinson & CO Call Options Transaction History

Point72 Middle East Fze

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$232.24 - $267.23 $580,600 - $668,075	2,500 Added 67.57%	6,200 $1.51 Million
Q3 2023 Nov 14, 2023	BUY	$254.9 - $283.59 $713,720 - $794,051	2,800 Added 311.11%	3,700 $956,000
Q2 2023 Aug 14, 2023	BUY	$238.39 - $265.32 $119,195 - $132,660	500 Added 125.0%	900 $237,000
Q1 2023 May 15, 2023	SELL	$229.71 - $259.35 $137,826 - $155,610	-600 Reduced 60.0%	400 $99,000
Q4 2022 Feb 14, 2023	BUY	$218.29 - $256.91 $218,290 - $256,910	1,000 New	1,000 $0

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.9B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

Stay updated on Point72 Middle East Fze with notifications on news.